These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

690 related articles for article (PubMed ID: 20806386)

  • 1. The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome.
    Tyrrell JS; Campbell SM; Curnow A
    Lasers Surg Med; 2010 Sep; 42(7):613-9. PubMed ID: 20806386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of an oxygen pressure injection (OPI) device on the oxygen saturation of patients during dermatological methyl aminolevulinate photodynamic therapy.
    Blake E; Allen J; Thorn C; Shore A; Curnow A
    Lasers Med Sci; 2013 May; 28(3):997-1005. PubMed ID: 22926533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring the accumulation and dissipation of the photosensitizer protoporphyrin IX during standard dermatological methyl-aminolevulinate photodynamic therapy utilizing non-invasive fluorescence imaging and quantification.
    Tyrrell J; Campbell SM; Curnow A
    Photodiagnosis Photodyn Ther; 2011 Mar; 8(1):30-8. PubMed ID: 21333932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: a retrospective analysis of response in 462 patients.
    Fai D; Arpaia N; Romano I; Vestita M; Cassano N; Vena GA
    G Ital Dermatol Venereol; 2009 Jun; 144(3):281-5. PubMed ID: 19528909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of protoporphyrin IX accumulation and destruction during methylaminolevulinate photodynamic therapy of skin tumours located at acral and nonacral sites.
    Tyrrell JS; Morton C; Campbell SM; Curnow A
    Br J Dermatol; 2011 Jun; 164(6):1362-8. PubMed ID: 21564050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protoporphyrin IX photobleaching during the light irradiation phase of standard dermatological methyl-aminolevulinate photodynamic therapy.
    Tyrrell J; Campbell S; Curnow A
    Photodiagnosis Photodyn Ther; 2010 Dec; 7(4):232-8. PubMed ID: 21112545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a non-invasive fluorescence imaging system to monitor dermatological PDT.
    Tyrrell J; Campbell S; Curnow A
    Photodiagnosis Photodyn Ther; 2010 Jun; 7(2):86-97. PubMed ID: 20510303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A quantitative comparison of 5-aminolaevulinic acid- and methyl aminolevulinate-induced fluorescence, photobleaching and pain during photodynamic therapy.
    Valentine RM; Ibbotson SH; Brown CT; Wood K; Moseley H
    Photochem Photobiol; 2011; 87(1):242-9. PubMed ID: 21077899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the pain of topical photodynamic therapy with methyl aminolevulinate any different from that with 5-aminolaevulinic acid?
    Ibbotson SH; Valentine R; Hearn R
    Photodermatol Photoimmunol Photomed; 2012 Oct; 28(5):272-3. PubMed ID: 22971196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The France-PDT study: a national prospective observational cohort survey on the use of methyl-aminolevulinate photodynamic therapy in France, with up to 6-month follow-up.
    Farhi D; Bedane C; Savary J; Basset-Seguin N
    Eur J Dermatol; 2013; 23(1):68-76. PubMed ID: 23400280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of acute postoperative hypertension after topical photodynamic therapy for non-melanoma skin cancer.
    Borroni RG; Carugno A; Rivetti N; Arbustini E; Brazzelli V
    Photodermatol Photoimmunol Photomed; 2013 Apr; 29(2):73-7. PubMed ID: 23458390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma.
    Dijkstra AT; Majoie IM; van Dongen JW; van Weelden H; van Vloten WA
    J Eur Acad Dermatol Venereol; 2001 Nov; 15(6):550-4. PubMed ID: 11843215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protoporphyrin IX formation after application of methyl aminolevulinate on the face and scalp with and without prior curettage.
    Heerfordt IM; Bieliauskiene G; Wulf HC
    Photodiagnosis Photodyn Ther; 2018 Jun; 22():155-157. PubMed ID: 29601904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the thin layer of methyl aminolevulinate used during photodynamic therapy sufficient?
    Wiegell SR; Lerche CM; Wulf HC
    Photodermatol Photoimmunol Photomed; 2016 Mar; 32(2):88-92. PubMed ID: 26577455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current methods for photodynamic therapy in the US: comparison of MAL/PDT and ALA/PDT.
    Lee PK; Kloser A
    J Drugs Dermatol; 2013 Aug; 12(8):925-30. PubMed ID: 23986167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression Analysis of Protoporphyrin IX Measurements Obtained During Dermatological Photodynamic Therapy.
    Tyrrell J; Paterson C; Curnow A
    Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30634715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [PDT panoramic view. Principle, photosensitizers, light sources and validated indications in dermatology].
    Basset-Seguin N
    Ann Dermatol Venereol; 2013 Nov; 140 Suppl 2():223-8. PubMed ID: 24199714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of air cooling pain relief on protoporphyrin IX photobleaching and clinical efficacy during dermatological photodynamic therapy.
    Tyrrell J; Campbell SM; Curnow A
    J Photochem Photobiol B; 2011 Apr; 103(1):1-7. PubMed ID: 21277787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased protoporphyrin IX accumulation does not improve the effect of photodynamic therapy for actinic keratosis: a randomized controlled trial.
    Nissen CV; Heerfordt IM; Wiegell SR; Mikkelsen CS; Wulf HC
    Br J Dermatol; 2017 May; 176(5):1241-1246. PubMed ID: 27696393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optical coherence tomography imaging of non-melanoma skin cancer undergoing photodynamic therapy reveals subclinical residual lesions.
    Themstrup L; Banzhaf CA; Mogensen M; Jemec GB
    Photodiagnosis Photodyn Ther; 2014 Mar; 11(1):7-12. PubMed ID: 24280439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.